The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

By The Associated Press The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use ...

They are getting a major change. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s ...

Limiting access stops healthy adults and children living with elderly or immunocompromised family members from choosing to do ...

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

That's the same limit the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...